Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Irving, Texas 25 trials found
New Search
Filter
Trial Phase
Study Type
Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial
PHASE2INTERVENTIONAL Dallas, Texas
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Tirzepatide Weight Loss for MRD+ Early Breast Cancer
PHASE2INTERVENTIONAL Dallas, Texas
RECRUITING
Study of XB010 in Subjects With Solid Tumors
PHASE1INTERVENTIONAL Irvine, California +4 more
RECRUITING
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
PHASE1INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
Falcon Real World Evidence Registry
N/AOBSERVATIONAL Evanston, Illinois +1 more
RECRUITING
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Childhood Cancer Survivor Study
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
The PREDICT Registry:
N/AOBSERVATIONAL Scottsdale, Arizona +4 more
RECRUITING
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
GammaPod Registry and Quality of Life Nomogram
N/AOBSERVATIONAL Bel Air, Maryland +3 more
RECRUITING
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
N/AOBSERVATIONAL Dallas, Texas
RECRUITING
Converting HR+ Breast Cancer Into an Individualized Vaccine
PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Pan Tumor Rollover Study
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC
EARLY_PHASE1INTERVENTIONAL Dallas, Texas
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
Connect for Cancer Prevention Study (Connect)
N/AOBSERVATIONAL Denver, Colorado +4 more
RECRUITING
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
PHASE2INTERVENTIONAL Dallas, Texas +1 more
RECRUITING
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type